The effect of food on the pharmacokinetics of ofloxacin
- 1 January 1986
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 10 (3) , 166-171
- https://doi.org/10.1185/03007998609110436
Abstract
SummaryAfter oral administration of a single dose of ofloxacin (300 mg), with and without a standard breakfast, to 12 healthy male volunteers in an open, randomized crossover study, concentrations of the unchanged drug were estimated at various times in serum and urine, over 28 hours and 48 hours, respectively. Each dose was followed by a wash-out period of 1 week. Ofloxacin concentrations were determined using high pressure liquid chromatography (HPLC): parallel determinations using a microbiological assay were in close agreement. Maximum serum concentrations (Cmax) of ofloxacin, after fasting and with breakfast, respectively, were 3.7 and 3.1 µg/ml (HPLC, median values). The corresponding areas under the serum concentration-time curves (AUC0–28) were 29.9 and 24.5 µg.h/ml. The lower values of Cmax and AUC0–28 found after food intake were statistically significant (p<0.05) but not clinically relevant when compared to the fasting values. Time to reach Cmax and terminal elimination half-life (t1/2β) were n...Keywords
This publication has 12 references indexed in Scilit:
- Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patientsInfection, 1986
- Zusammengefaßte Ergebnisse der klinischen Phase II- und III-Studien mit Ofloxacin (HOE 280) in EuropaInfection, 1986
- Atemwegsinfektionen — Klinische Ergebnisse mit OfloxacinInfection, 1986
- Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogensAntimicrobial Agents and Chemotherapy, 1985
- Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1985
- Comparative Evaluation of Recently Developed Quinolone Compounds – with a Note on the Frequency of Resistant MutantsChemotherapy, 1985
- Norfloxacin--a review of pharmacology and tissue penetrationJournal of Antimicrobial Chemotherapy, 1984
- Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analoguesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- DNA TopoisomerasesAnnual Review of Biochemistry, 1981
- DNA Gyrase and the Supercoiling of DNAScience, 1980